Ironwood Pharmaceuticals, Inc. (IRWD)
3.42
-0.24
(-6.56%)
USD |
NASDAQ |
Feb 27, 16:00
3.41
-0.01
(-0.29%)
After-Hours: 07:35
Ironwood Pharmaceuticals Research and Development Expense (Annual) : 93.26M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| AbbVie, Inc. | 8.249B |
| Outlook Therapeutics, Inc. | 27.78M |
| Nektar Therapeutics | 119.64M |
| Rigel Pharmaceuticals, Inc. | 23.38M |
| Recursion Pharmaceuticals, Inc. | 425.27M |